Owlstone Medical Ltd. received $6.5 million in funding from the Bill & Melinda Gates Foundation which will go towards ...

After investing $24 billion in three major acquisitions earlier this year, Bristol Myers Squibb Co. said April 25 it would ...

Biolojic Design Ltd. announced that Nektar Therapeutics Inc. has exercised its license option to develop a program resulting ...

With a frozen IPO market, investors are tightening their belts and figuring out where to hedge their bets. In Asia, that ...

Ono Pharmaceutical Co. Ltd. has entered into a drug discovery collaboration agreement with Prism Biolab Co. Ltd. to generate ...

Acrivon Therapeutics Inc.’s $130 million financing disclosed April 9 hiked confidence in then-pending data with ACR-368 ...

The U.S. FDA’s device center launched a new health care program designed to provide patients with a seamless home health care ...

Seven years after embarking on in vivo therapeutic development using CRISPR/Cas gene-editing technology with Intellia Therapeutics Inc., Regeneron Pharmaceuticals Inc. is bringing another company into ...

Singapore- and U.S.-based Sunbird Bio Pte Ltd. is advancing its blood-based diagnostics platform for neurological diseases like Alzheimer’s and Parkison’s disease (AD/PD), amidst new breakthroughs in ...

The Chinese National Institutes of Pharmaceutical Research & Development has divulged nitrogen-containing heterocyclic compounds acting as poly(ADP-ribose) polymerase 1 (PARP-1; ARTD1) inhibitors ...

In one of the biggest startups ever, Xaira Therapeutics has launched with more than $1 billion from investors. The financing, ...

South Korean med-tech companies Nunaps Co. Ltd. and Share & Service are the latest to clear domestic approvals for digital ...